You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
昆藥集團(600422.SH):昆藥商業擬在雲南省臨滄市與廣康藥業合資新設子公司
格隆匯 11-20 18:11

格隆匯11月20日丨昆藥集團(600422.SH)公佈,為繼續實施“深耕雲南、佈局終端”戰略,昆藥集團醫藥商業有限公司(“昆藥商業”)擬在臨滄市臨翔區與臨滄市廣康藥業有限公司(“廣康藥業”)合資新設“昆藥商業(臨滄)醫藥有限公司”(暫定名,以工商登記部門核准為依據),註冊資本1000萬元。

臨滄公司經營範圍(暫定,以工商登記部門核准為依據):藥品、醫療器械、醫療用品及器械、麻醉藥品、第一類精神藥品、第二類精神藥品製劑;保健食品、預包裝食品、消毒用品、消毒器械、化粧品及衞生用品、日用百貨的銷售、配送服務;貨物或技術進出口(國家禁止或涉及行政審批的貨物和技術進出口除外);倉儲服務(不含易燃易爆等危險化學品);普通貨物道路運輸;醫藥信息諮詢服務;會議及展覽服務;廣告的設計;製作、代理、發佈;計算機系統集成及綜合佈線。(依法須經批准的項目,經相關部門批准後方可開展經營活動)

廣康藥業是臨滄市目前唯一一家擁有一類毒、麻經營資質的醫藥公司,在臨 滄市全區域縣級及以上醫療機構已全開户併合作。

合同顯示,昆藥商業和臨滄公司雙方在雲南省臨滄市臨翔區開發區按昆藥商業 51%、臨滄公司49%的股權比例合資新設目標公司。目標公司註冊資本1000萬元,由昆藥商業和臨滄公司按其股權比例以貨幣資金認繳出資,實際出資進度按目標公司經營需求分期由昆藥商業和臨滄公司雙方同時按股權比例出資。

臨滄公司的成立預計對公司2019年度的資產總額、淨資產和淨利潤等不構成重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account